drugset / Trial / NCT00630695
Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer
RandomizedParallel-groupDouble-blindPrevention
Summary
Injection the day before surgery of 90 mg of Lanreotide LP sub-cutaneously or placebo. Evaluation of the lymphorrhea in the 2 arms of the study
Timeline
- Start
- 2008-03
- Primary completion
- 2011-06
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lanreotide | Other / unclassified | 90 mg | Subcutaneous |